AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
DOLUTEGRAVIR SODIUM/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE in Ghana
2 products registered with FDA Ghana — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR SODIUM/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE | UNKNOWN-ed4fa2d9 | — | active | 1 Aug 2030 |
| DOLUTEGRAVIR SODIUM/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE | UNKNOWN-e2aca8f2 | — | active | 1 Aug 2030 |
DOLUTEGRAVIR SODIUM/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing DOLUTEGRAVIR SODIUM/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE, of which 2 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track DOLUTEGRAVIR SODIUM/ LAMIVUDINE/ TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.